ArticleAlzheimer's research & therapy2013

Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood-brain barrier model.

Sabrina Meister et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.